Treatment may be offered to hundreds with severe form of disease, most often found in people of Mediterranean, Asian and Middle Eastern heritage
People living with a rare genetic blood disorder in England will be offered a “life-changing” new treatment on the NHS, in what has been described as a historic moment.
Casgevy, which is a one-off gene therapy, has been approved for use on the NHS in England for people living with a severe form of thalassaemia.
More Stories
Over 150k more people in England have ME than previously thought, study finds
Teenagers who go to bed early and sleep longer have sharper brains, study finds
Revealed: Chinese researchers can access half a million UK GP records